• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nasdaq Gains Over 200 Points; Dentsply Sirona Shares Fall After Q1 Results

    5/2/24 2:45:31 PM ET
    $ASPN
    $CVNA
    $EBS
    $FSLY
    RETAIL: Building Materials
    Consumer Discretionary
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary
    Get the next $ASPN alert in real time by email

    U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite surging over 200 points on Thursday.

    The Dow traded up 0.87% to 38,234.10 while the NASDAQ rose 1.45% to 15,832.17. The S&P 500 also rose, gaining, 0.90% to 5,063.69.

    Check This Out: Top 4 Defensive Stocks You’ll Regret Missing This Quarter

    Leading and Lagging Sectors

    Information technology shares rose by 1.1% on Thursday.

    In trading on Thursday, materials shares fell by 0.8%.

    Top Headline

    Dentsply Sirona Inc. (NASDAQ:XRAY) shares fell around 5% on Thursday after reporting first-quarter results.

    The company reported adjusted earnings per share of 42 cents, in line with the street view. Quarterly revenues of $953 million missed the street view of $969.136 million.

    Equities Trading UP
                           

    • Aspen Aerogels, Inc.. (NYSE:ASPN) shares shot up 52% to $23.11 after the company reported better-than-expected first-quarter financial results.
    • Shares of Emergent BioSolutions Inc. (NYSE:EBS) got a boost, surging 100% to $3.8616 after the company announced operational changes to stabilize its financial position and reported first-quarter financial results.
    • Carvana Co. (NYSE:CVNA) shares were also up, gaining 30% to $112.98 after the company reported upbeat sales for the first quarter.

    Equities Trading DOWN

    • Fastly, Inc. (NYSE:FSLY) shares dropped 34% to $8.49 after the company reported first-quarter financial results.
    • Shares of Vestis Corporation (NYSE:VSTS) were down 40% to $11.07 after the company reported worse-than-expected second-quarter results and lowered its fiscal 2024 outlook.
    • XPEL, Inc. (NASDAQ:XPEL) was down, falling 33% to $36.31 after the company reported worse-than-expected first-quarter financial results and slashed its annual revenue growth projection.

    Also Check This Out: Jim Cramer: This PC Maker Is A ‘Good Stock To Own’, Okta Is ‘Terrific’

    Commodities

    In commodity news, oil traded down 0.1% to $78.94 while gold traded up 0.2% at $2,316.20.

    Silver traded up 0.3% to $26.83 on Thursday, while copper fell 1.3% to $4.4850.

    Euro zone

    European shares were mixed today. The eurozone's STOXX 600 fell 0.22%, Germany's DAX fell 0.20% and France's CAC 40 fell 0.88%. Spain's IBEX 35 Index gained 0.16%, while London's FTSE 100 rose 0.63%.

    The HCOB Eurozone manufacturing PMI edged higher to 45.7 in April versus the preliminary reading of 45.6. Germany's manufacturing PMI climbed to 42.5 in April from 41.9 in the prior month, while French manufacturing PMI declined to 45.3 in April versus 46.2 in March.

    Asia Pacific Markets

    Asian markets closed mostly higher on Wednesday, with Japan's Nikkei 225 falling 0.10%, Hong Kong's Hang Seng Index jumping 2.5% and S&P BSE Sensex gaining 0.17%.

    Hong Kong's economy grew 2.7% year-over-year in the first quarter compared to a 4.3% increase in the prior period, while the Hong Kong Monetary Authority kept its base rate unchanged at 5.75%.

    The HSBC India manufacturing PMI was revised lower to 58.8 in April compared to preliminary reading of 59.1. The consumer confidence index for Japan fell to 38.3 in April versus 39.5 a month ago.                                

    Economics

    • The trade deficit in the US narrowed slightly to $69.4 billion in March versus a revised $69.5 billion gap in February.
    • Exports of goods and services fell by $5.3 billion to $257.6 billion in March, while imports into the US fell by 1.6% to $327 billion.
    • U.S. initial jobless claims came in unchanged from the previous week at 208,000 during the week ending April 27, compared to market expectations of 212,000.
    • Unit labor costs in the U.S. nonfarm business sector rose an annualized 4.7%, while nonfarm business sector labor productivity increased by 0.3% in the first quarter.
    • U.S. factory orders increased by 1.6% from the prior month to $584.5 billion in March.
    • U.S. natural-gas supplies increased 59 billion cubic feet during the week ended April 26.

    Now Read This: Wall Street’s Most Accurate Analysts Say Buy These 3 Utilities Stocks With Over 3% Dividend Yields

    Get the next $ASPN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASPN
    $CVNA
    $EBS
    $FSLY

    CompanyDatePrice TargetRatingAnalyst
    DENTSPLY SIRONA Inc.
    $XRAY
    2/19/2026$17.00Neutral → Buy
    BofA Securities
    Fastly Inc.
    $FSLY
    2/12/2026Mkt Perform → Outperform
    William Blair
    Vestis Corporation
    $VSTS
    1/8/2026$5.30Neutral → Sell
    Goldman
    Carvana Co.
    $CVNA
    12/15/2025$500.00Buy
    Argus
    DENTSPLY SIRONA Inc.
    $XRAY
    12/9/2025$12.00Underweight
    Barclays
    Carvana Co.
    $CVNA
    12/1/2025$450.00Buy
    UBS
    Carvana Co.
    $CVNA
    11/24/2025$400.00Neutral → Outperform
    Wedbush
    Carvana Co.
    $CVNA
    11/21/2025$395.00Buy
    Deutsche Bank
    More analyst ratings

    $ASPN
    $CVNA
    $EBS
    $FSLY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President, CEO & Member of BOD Scavilla Daniel T covered exercise/tax liability with 1,194 shares, decreasing direct ownership by 7% to 16,750 units (SEC Form 4)

    4 - DENTSPLY SIRONA Inc. (0000818479) (Issuer)

    2/26/26 4:31:06 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Chief Technology Officer Bergman Artur sold $683,200 worth of shares (40,000 units at $17.08) (SEC Form 4)

    4 - Fastly, Inc. (0001517413) (Issuer)

    2/25/26 5:14:00 PM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    Chief Technology Officer Bergman Artur sold $1,448,203 worth of shares (74,457 units at $19.45), decreasing direct ownership by 2% to 1,842,532 units (SEC Form 4)

    4 - Fastly, Inc. (0001517413) (Issuer)

    2/23/26 4:55:18 PM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    $ASPN
    $CVNA
    $EBS
    $FSLY
    SEC Filings

    View All

    SEC Form 10-K filed by XPEL Inc.

    10-K - XPEL, Inc. (0001767258) (Filer)

    2/27/26 8:59:27 AM ET
    $XPEL
    Industrial Specialties
    Industrials

    SEC Form 10-K filed by DENTSPLY SIRONA Inc.

    10-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    2/26/26 4:54:01 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    DENTSPLY SIRONA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - DENTSPLY SIRONA Inc. (0000818479) (Filer)

    2/26/26 4:13:30 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $ASPN
    $CVNA
    $EBS
    $FSLY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Carvana to Present at Upcoming Morgan Stanley Technology, Media & Telecom Conference

    Carvana (NYSE:CVNA), a leading e-commerce platform for buying and selling cars, today announced that Ernie Garcia, Carvana's Founder and Chief Executive Officer, will present to the investor community and host meetings at the upcoming Morgan Stanley Technology, Media & Telecom Conference. Morgan Stanley Technology, Media & Telecom Conference Presentation Date and Time: Monday, March 2, 2026, at 12:20 PM PT* *A webcast of the presentation will be accessible on the Investor Relations section of the Carvana website (https://investors.carvana.com). An archived replay of the webcast will be available following the live presentation. About Carvana Carvana's mission is to change the way pe

    2/27/26 8:00:00 AM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook

    News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action Plan, prioritizing investments in accelerated innovation, clinical education, and sales team education focused on connected dentistryInitiated new capital allocation strategy by eliminating the dividend

    2/26/26 4:01:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $ASPN
    $CVNA
    $EBS
    $FSLY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Dentsply Sirona upgraded by BofA Securities with a new price target

    BofA Securities upgraded Dentsply Sirona from Neutral to Buy and set a new price target of $17.00

    2/19/26 7:47:02 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Fastly upgraded by William Blair

    William Blair upgraded Fastly from Mkt Perform to Outperform

    2/12/26 7:17:35 AM ET
    $FSLY
    Computer Software: Prepackaged Software
    Technology

    Vestis downgraded by Goldman with a new price target

    Goldman downgraded Vestis from Neutral to Sell and set a new price target of $5.30

    1/8/26 8:43:37 AM ET
    $VSTS
    Consumer Specialties
    Consumer Discretionary

    $ASPN
    $CVNA
    $EBS
    $FSLY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Pertz Douglas A bought $172,445 worth of shares (25,000 units at $6.90), increasing direct ownership by 8% to 322,010 units (SEC Form 4)

    4 - Vestis Corp (0001967649) (Issuer)

    12/22/25 4:29:05 PM ET
    $VSTS
    Consumer Specialties
    Consumer Discretionary

    Director Meister Keith A. bought $6,874,339 worth of shares (1,010,064 units at $6.81) (SEC Form 4)

    4 - Vestis Corp (0001967649) (Issuer)

    12/17/25 6:20:39 PM ET
    $VSTS
    Consumer Specialties
    Consumer Discretionary

    Director Goetz William bought $50,082 worth of shares (6,746 units at $7.42), increasing direct ownership by 29% to 29,877 units (SEC Form 4)

    4 - Vestis Corp (0001967649) (Issuer)

    12/9/25 5:19:34 PM ET
    $VSTS
    Consumer Specialties
    Consumer Discretionary

    $ASPN
    $CVNA
    $EBS
    $FSLY
    Leadership Updates

    Live Leadership Updates

    View All

    Dentsply Sirona Appoints James Forbes and Brian McKeon to Board of Directors

    CHARLOTTE, N.C., Feb. 24, 2026 (GLOBE NEWSWIRE) --  DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointments of James (Jim) D. Forbes and Brian P. McKeon to its Board of Directors (the "Board"), effective February 27, 2026. Mr. Forbes is a veteran healthcare investment banker with 30 years of experience helping companies develop strategies to drive profitable growth and long-term value creation. Mr. Forbes is widely recognized for advising healthcare companies on complex strategic transactions and capital markets engagements. He most recently served as Vice Chairman of Investment Banking at Morgan Stanley, and he previously held senior execu

    2/24/26 4:30:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Donald Zurbay to Board of Directors

    CHARLOTTE, N.C., Jan. 13, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY) today announced the appointment of Donald (Don) Zurbay to its Board of Directors (the "Board"), effective January 10, 2026. He will be joining the Board's Audit and Finance Committee. Mr. Zurbay brings extensive leadership experience in the dental and healthcare industries, and value creation across complex, global organizations. He most recently served as President and Chief Executive Officer (CEO) of Patterson Companies, following his tenure as Chief Financial Officer (CFO) from 2018 to 2022. During his tenure, Patterson maintained a longstanding dealer partnership

    1/13/26 8:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Dentsply Sirona Appoints Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization

    CHARLOTTE, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. ("Dentsply Sirona" or the "Company") (NASDAQ:XRAY), the world's largest diversified manufacturer of professional dental products and technologies, today announced the appointment of Mark R. Bezjak as Group Vice President, Americas Regional Commercial Organization, effective January 28. The appointment supports Dentsply Sirona's continued focus on strengthening commercial execution, deepening customer relationships and accelerating growth across the Americas. Mr. Bezjak is a seasoned commercial executive with more than 20 years of experience leading large-scale, multi-billion-dollar organizations in the medical device

    1/12/26 9:00:00 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    $ASPN
    $CVNA
    $EBS
    $FSLY
    Financials

    Live finance-specific insights

    View All

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dentsply Sirona Reports Fourth Quarter and Full Year 2025 Results, Provides Full Year 2026 Outlook

    News Summary Q4 2025 net sales of $961 million increased 6.2%, constant currency sales increased 2.5%Q4 2025 reported net loss of ($146) million and diluted loss per share of ($0.74) driven by goodwill and intangible impairments of ($144) million, net of taxQ4 2025 adjusted EPS of $0.27FY 2026 outlook: net sales in the range of $3.5B to $3.6B; adjusted EPS of $1.40 to $1.50(1)Announced a restructuring initiative to redirect approximately $120 million annually into the Return-to-Growth Action Plan, prioritizing investments in accelerated innovation, clinical education, and sales team education focused on connected dentistryInitiated new capital allocation strategy by eliminating the dividend

    2/26/26 4:01:00 PM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    XPEL Reports Revenue Growth of 13.7% to $122.3 million, EBITDA Growth of 37.6% to $19.6 million in Fourth Quarter 2025

    XPEL, Inc. (NASDAQ:XPEL) (the "Company"), a global provider of protective films and coatings, announced consolidated results1 for the fourth quarter and year end 2025. Fourth Quarter 2025 Overview: Revenue increased 13.7% to $122.3 million in the fourth quarter of 2025 compared to $107.5 million in the fourth quarter of 2024. Gross margin of 41.9% in the fourth quarter of 2025 compared to 40.6% in the same quarter last year. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) increased 37.6% to $19.6 million, or 16.0% of revenue, compared to $14.3 million, or 13.3% of revenue in the fourth quarter of 2024. Net income attributable to stockholders of the com

    2/25/26 8:30:00 AM ET
    $XPEL
    Industrial Specialties
    Industrials

    $ASPN
    $CVNA
    $EBS
    $FSLY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Carvana Co.

    SC 13D/A - CARVANA CO. (0001690820) (Subject)

    12/16/24 6:13:26 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by DENTSPLY SIRONA Inc.

    SC 13G/A - DENTSPLY SIRONA Inc. (0000818479) (Subject)

    12/6/24 10:11:29 AM ET
    $XRAY
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Carvana Co.

    SC 13G/A - CARVANA CO. (0001690820) (Subject)

    11/14/24 5:58:14 PM ET
    $CVNA
    Retail-Auto Dealers and Gas Stations
    Consumer Discretionary